The scores of NVC findings in all DM-ILD patients are shown in Supplementary Table S1, and those between the anti-MDA5 antibody-positive and anti-ARS antibody-positive patients are shown in Table 2. This evidence concerns the gene IFIH1 and dermatomyositis.